Blog - Page 3820 of 5725

TuesdayJun 29, 2010 3:03 pm

Beacon Equity Research Featured Company: Vidaroo Corp. (VIDA.OB)

Vidaroo Corp. is an emerging leader in integrated digital media and technology solutions, with vast expertise in marketing, content creation, post-production, which is structured around one driving central premise held dear by both the Board of Directors and executive management, as well as its entire staff: sustainable profitability. An intuitive yet robust online video platform for managing and delivering content, the Company’s sophisticated Digital Video Publisher enables users to extend existing sites into web-based TV networks. With easily embeddable channels and video, users can reach massive new markets through viral promotion and organic information seeding on social networking sites. With…

TuesdayJun 29, 2010 2:10 pm

Wall Street Rocked by Continued Economy Fears

Stocks continued their slump in Tuesday’s mid-day trading after data reporting that U.S. consumer confidence fell in June, paired with concern over Europe’s fiscal challenges. An hour from the market close, the Dow (DJI) lost 236.93 points, 2.43 percent, to 9,901.59, marking the first time the index dropped below 10,000 since June 10; the S&P 500 gave up 28.81 points, or 2.68 percent, to 1,045.07; and the Nasdaq fell 72.99 points, 3.29 percent to 2,147.43. U.S. stocks are set to post their first quarterly decline since the first quarter of 2009, curtailing from four consecutive quarters of gains; and second-quarter…

TuesdayJun 29, 2010 1:54 pm

Cellceutix Corp. (CTIX.OB) Backed by Seasoned Management Team

Cellceutix Corp. develops small molecule therapies for treatment of cancer, autism and inflammatory disease. The company is supported by a panel of officers and advisors with extensive experience and knowledge in the fields of cancer and genetics, as well as with wide experience in the pharmaceutical business and relative researching, developing and marketing. Most of the company’s efforts center on the company’s lead product Kevetrin, which is in development for drug-resistant cancers. Cellceutix is concluding final studies before applying for FDA approval for human studies. The company’s focus is maintained by a strong management team and a shared commitment to…

TuesdayJun 29, 2010 12:24 pm

OriginOil, Inc. (OOIL.OB) Appoints Algae Industry Luminary Brian Goodall as CTO

OriginOil, Inc., www.originoil.com – a leader in the breakthrough technology of using large-scale algae farming techniques for the production of renewable oil that can directly compete with petroleum, announced the appointment of Brian Goodall, Ph.D. as its new CTO today. As OOIL’s strategic partner, Desmet Ballestra North America, Inc. President and CEO Timothy Kemper, puts it, Brian Goodall has prior experience working closely with them when he was VP of Downstream Technology at Sapphire Energy, and has Kemper’s “personal confidence and support”. Goodall’s work at Sapphire with Continental Airlines led to the first commercial US flight demo using an algae-oil…

TuesdayJun 29, 2010 12:22 pm

Public Media Works, Inc. (PUBM.OB) Moves to Acquire VideomaticCanada

Public Media Works, Inc., www.publicmediaworks.com – the technologically-forward leader in entertainment which also distributes demographically relevant digital media via subsidiary, EntertainmentXpress (using a self-service kiosk architecture), disclosed details about the signing of a Letter of Intent to acquire Ventures, Inc., DBA VideomaticCanada, today. Consistent with ongoing PUBM due diligence, the companies anticipate an all-stock transaction within six to eight weeks. Current growth rate projections indicate that VideomaticCanada is well on its way to achieving the goal, set by management, of becoming Canada’s largest DVD kiosk network in 2010. VideomaticCanada is currently Canada’s second largest DVD and videogame kiosk network, with…

TuesdayJun 29, 2010 12:19 pm

US Dataworks, Inc. (UDWK) Reports Profit in First Quarter of 2010

US Dataworks, Inc. reported net income of $85,379 or $0.00 per share, in the first quarter that ended 3/31/2010. The company reported a net loss of $181,221, or $0.01 per share, in the corresponding quarter of 2009. Revenue increased on a year over year basis in the first quarter of 2010 to $2.1 million from the $1.8 million reported in the first quarter of 2009. The segment showing the biggest improvement was the software licensing business. Charles E. Ramey, the CEO of US Dataworks, Inc. sounded upbeat about the upcoming year for the company. “We entered fiscal 2010 as a…

TuesdayJun 29, 2010 12:18 pm

China Cablecom Holdings, Ltd. (CABL) Reports Large Increase in First Quarter Revenues

China Cablecom Holdings, Ltd. reported that sales in the first quarter of 2010 were $13.4 million, compared to $10 million in the first quarter of 2009. The management of the company attributed the large increase to strong growth in its subscriber base, and higher subscription and installation fees. Clive Ng, the Executive Chairman of China Cablecom Holdings, Ltd., said, “We are so pleased to be reporting such a strong quarter. The performance of both operations in Binzhou and Hubei have exceeded our expectations and delivered significant growth in revenues, EBITDA, subscription, digitization and ARPU.” China Cablecom Holdings, Ltd. reported that…

TuesdayJun 29, 2010 11:02 am

Alimera Sciences, Inc. (ALIM) Submits New Drug Application for Treatment of Diabetic Macular Edema

One company that is starting to earn attention within the pharmaceutical sector is Alimera Sciences, Inc. Located in Alpharetta, Georgia, Alimera is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Today, Alimera took a major step towards enhancing its future with the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Iluvien. Iluvien is Alimera’s investigational sustained drug delivery system releasing sub-microgram levels of fluocinolone acetonide for the treatment of diabetic macular edema (DME). In the submission, Alimera requested priority review, which, if granted, could result…

TuesdayJun 29, 2010 9:43 am

OurPet’s Company (OPCO.OB) Signs Purchase Agreement for Cosmic Pet Products

OurPet’s Company announced today that they have entered into an asset purchase agreement to acquire certain assets of Cosmic Pet Products. Under the terms of the agreement, OurPet’s will acquire all of Cosmic Pet’s brands including the well-known Cosmic Catnip line. Completion of the transaction is subject to due diligence by OurPet's and other standard conditions to closing; however, it is expected to close during the third quarter of 2010. Per the agreement, Cosmic Pet will continue operations at its Hagerstown, Maryland facility as a division of OurPet’s. Part of the plan also includes for OurPet’s to enter into an…

TuesdayJun 29, 2010 8:47 am

ALR Technologies (ALRT.OB) Announces Board Changes; New President and Chief Operating Officer Appointed

ALR Technologies, Inc. announced yesterday the appointment of Lawrence (Larry) Weinstein as President and Chief Operating Officer. Mr. Weinstein will assume the positions as of July 1, 2010 and be replacing Sidney Chan who will become Chairman and Chief Executive Officer upon the retirement of Stanley Cruitt who had been serving as ALR’s Chairman. Mr. Weinstein will be departing his roles as Senior Vice President of Operations at PRE Holding, Inc. and as President of Hydrate, Inc. to assume the new position with ALR. Mr. Weinstein has extensive experience in the development and launch of medical products including 11 years…

Site Search

Company Search